{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:12:41Z","timestamp":1793769161329,"version":"4.6.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41366-021-01045-4","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:04:08Z","timestamp":1642118648000},"page":"707-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Vitamin D deficiency: a potential risk factor for cancer in obesity?"],"prefix":"10.1038","volume":"46","author":[{"given":"Silvia","family":"Migliaccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Magno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-456X","authenticated-orcid":false,"given":"Luigi","family":"Barrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-4931","authenticated-orcid":false,"given":"Giovanna","family":"Muscogiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"1045_CR1","first-page":"1","volume":"894","author":"Obesity: preventing and managing the global epidemic.","year":"2000","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1\u2013253.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","volume":"378","author":"YC Wang","year":"9793","unstructured":"Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 9793;378:815\u201325.","journal-title":"Lancet"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","volume":"387","author":"NCD Risk","year":"2016","unstructured":"Risk NCD. Factor collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377\u201396.","journal-title":"Lancet"},{"issue":"Nov","key":"1045_CR4","doi-asserted-by":"publisher","first-page":"e79827","DOI":"10.1371\/journal.pone.0079827","volume":"8","author":"L Keaver","year":"2013","unstructured":"Keaver L, Webber L, Dee A, Shiely F, Marsh T, Balanda K, et al. Application of the UK foresight obesity model in Ireland: The health and economic consequences of projected obesity trends in Ireland. PLoS ONE. 2013;8(Nov):e79827.","journal-title":"PLoS ONE"},{"key":"1045_CR5","doi-asserted-by":"publisher","first-page":"e103483","DOI":"10.1371\/journal.pone.0103483","volume":"9","author":"MLM Ashwell","year":"2014","unstructured":"Ashwell MLM, Richardson J, Rickayzen B. Waist-to-height ratio is more predictive of years of life lost than body mass index. PLoS ONE. 2014;9:e103483.","journal-title":"PLoS ONE"},{"key":"1045_CR6","unstructured":"Fitch A, Fox C, Bauerly K, Gross A, Heim C, Judge-Dietz J, et al. Prevention and management of obesity for children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013."},{"issue":"2","key":"1045_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/jc.2013-2832","volume":"99","author":"K Aung","year":"2014","unstructured":"Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ijo.2009.184","volume":"33","author":"SB Heymsfield","year":"2009","unstructured":"Heymsfield SB, Scherzer R, Pietrobelli A, Lewis CE, Grunfeld C. Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample. Int J Obes. 2009;33:1363\u201373.","journal-title":"Int J Obes"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ijo.2010.5","volume":"34","author":"DO Okorodudu","year":"2010","unstructured":"Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes . 2010;34:791\u20139.","journal-title":"Int J Obes"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"316","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"1045_CR11","unstructured":"The Third Expert Report, DIet, nutrition, physical activity and cancer: a global perspective. Continuous Update Project Expert Report. https:\/\/www.wcrf.org\/dietandcancer."},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med. 2003;348:1625\u201338.","journal-title":"N Engl J Med"},{"issue":"Feb","key":"1045_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2017.10.020","volume":"48","author":"A Vecchi\u00e9","year":"2018","unstructured":"Vecchi\u00e9 A, Dallegri F, Carbone F, Bonaventura A, Liberale L, Portincasa P, et al. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med. 2018;48(Feb):6\u201317.","journal-title":"Eur J Intern Med"},{"key":"1045_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11883-017-0644-3","volume":"19","author":"L Liberale","year":"2017","unstructured":"Liberale L, Bonaventura A, Vecchie A, Matteo C, Dallegri F, Montecucco F, et al. The role of adipocytokines in coronary atherosclerosis. Curr Atheroscler Rep. 2017;19:10.","journal-title":"Curr Atheroscler Rep"},{"key":"1045_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/eurheartj\/ehm026","volume":"28","author":"L de Koning","year":"2007","unstructured":"de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. European Heart J. 2007;28:850\u20136.","journal-title":"European Heart J"},{"key":"1045_CR16","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/bjc.2017.106","volume":"116","author":"H Freisling","year":"2017","unstructured":"Freisling H, Arnold M, Soerjomataram I, O\u2019Doherty MG, Ordonez-Mena JM, Bamia C, et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer. 2017;116:1486\u201397.","journal-title":"Br J Cancer"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/jnci\/djj246","volume":"98","author":"T Pischon","year":"2006","unstructured":"Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920\u201331.","journal-title":"J Natl Cancer Inst"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canep.2011.03.001","volume":"3","author":"AM Ryan","year":"2011","unstructured":"Ryan AM, Duong M, Healy L, Ryan SA, Parekh N, Reynolds JV. et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol. 2011;3:309\u201319.","journal-title":"Cancer Epidemiol"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/nyas.13219","volume":"1376","author":"DD Bikle","year":"2016","unstructured":"Bikle DD. Extraskeletal actions of vitamin D. Ann N Y Acad Sci. 2016;1376:29\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"1045_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12018-009-9033-y","volume":"7","author":"DD Bikle","year":"2009","unstructured":"Bikle DD. Extra renal synthesis of 1,25 dihydroxyvitamin D and its Health Implications. Clin Rev Bone Min Metab. 2009;7:114\u201325.","journal-title":"Clin Rev Bone Min Metab"},{"key":"1045_CR21","first-page":"179","volume":"1","author":"MF Holick","year":"2014","unstructured":"Holick MF. Cancer, sunlight and vitamin D. J Clin Transl Endocrinol. 2014;1:179\u201386.","journal-title":"J Clin Transl Endocrinol"},{"key":"1045_CR22","doi-asserted-by":"publisher","first-page":"1548e54","DOI":"10.2215\/CJN.01350308","volume":"3","author":"MF Holick","year":"2008","unstructured":"Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548e54.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"8587e97","DOI":"10.1158\/0008-5472.CAN-10-1420","volume":"70","author":"DM Freedman","year":"2010","unstructured":"Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res. 2010;70:8587e97.","journal-title":"Cancer Res"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"708e11","DOI":"10.1016\/j.jsbmb.2006.12.007","volume":"103","author":"CF Garland","year":"2007","unstructured":"Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103:708e11.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Apr","key":"1045_CR25","first-page":"118","volume":"3","author":"R Nair","year":"2012","unstructured":"Nair R, Maseeh A. Vitamin D: the \u201csunshine\u201d vitamin. J Pharmacol Pharmacother. 2012;3(Apr):118\u201326.","journal-title":"J Pharmacol Pharmacother"},{"key":"1045_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/obr.12239","volume":"16","author":"M Pereira-Santos","year":"2015","unstructured":"Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16:341\u20139.","journal-title":"Obes Rev"},{"key":"1045_CR27","doi-asserted-by":"publisher","first-page":"pii: E1506","DOI":"10.3390\/nu11071506","volume":"11","author":"EA Greco","year":"2019","unstructured":"Greco EA, Lenzi A, Migliaccio S. Role of hypovitaminosis D in the pathogenesis of obesity-induced insulin resistance. Nutrients. 2019;11:pii: E1506.","journal-title":"Nutrients."},{"key":"1045_CR28","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1210\/jc.2016-3591","volume":"102","author":"A Di Nisio","year":"2017","unstructured":"Di Nisio A, De Toni L, Sabovic I, Rocca MS, De Filippis V, Opocher G, et al. Impaired release of vitamin D in dysfunctional adipose tissue: new cues on vitamin D supplementation in obesity. J Clin Endocrinol Metab. 2017;102:2564\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41367-019-0010-8","volume":"9","author":"S Migliaccio","year":"2019","unstructured":"Migliaccio S, Di Nisio A, Mele C, Scappaticcio L, Savastano S, Colao A. Obesity programs of nutrition, education, research and assessment (OPERA) group. Obesity and hypovitaminosis D: causality or casualty? Int J Obes Suppl. 2019;9:20\u201331.","journal-title":"Int J Obes Suppl"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","volume":"78","author":"G Jones","year":"1998","unstructured":"Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998;78:1193\u2013231.","journal-title":"Physiol. Rev."},{"key":"1045_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00394-012-0430-5","volume":"52","author":"S Battault","year":"2013","unstructured":"Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G, Maixent JM. Vitamin D metabolism, functions and needs: fromscience to health claims. Eur J Nutr. 2013;52:429\u201341.","journal-title":"Eur J Nutr"},{"issue":"Aug","key":"1045_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/er.2018-00126","volume":"40","author":"R Bouillon","year":"2019","unstructured":"Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40(Aug):1109\u201351.","journal-title":"Endocr Rev"},{"key":"1045_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ajcn\/85.3.860","volume":"85","author":"E Hypp\u00f6nen","year":"2007","unstructured":"Hypp\u00f6nen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860\u20138.","journal-title":"Am J Clin Nutr"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/ajcn\/34.11.2359","volume":"34","author":"JE Compston","year":"1981","unstructured":"Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981;34:2359\u201363.","journal-title":"Am J Clin Nutr"},{"key":"1045_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/nu5030949","volume":"5","author":"S Vanlint","year":"2013","unstructured":"Vanlint S. Vitamin D and obesity. Nutrients. 2013;5:949\u201356.","journal-title":"Nutrients."},{"key":"1045_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000490669","volume":"73","author":"FJ Ruiz-Ojeda","year":"2018","unstructured":"Ruiz-Ojeda FJ, Anguita-Ruiz A, Leis R, Aguilera CM. Genetic factors and molecular mechanisms of vitamin D and obesity relationship. Ann Nutr Metab. 2018;73:89\u201399.","journal-title":"Ann Nutr Metab"},{"key":"1045_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","volume":"72","author":"J Wortsman","year":"2000","unstructured":"Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690\u20133.","journal-title":"Am J Clin Nutr"},{"key":"1045_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/oby.2011.404","volume":"20","author":"AT Drincic","year":"2012","unstructured":"Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444\u20138.","journal-title":"Obesity (Silver Spring)"},{"key":"1045_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jbmr.2979","volume":"32","author":"A Carrelli","year":"2016","unstructured":"Carrelli A, Bucovsky M, Horst R, Cremers S, Zhang C, Bessler M, et al. Vitamin D storage in adipose tissue of obese and normal weight women. J Bone Miner Res. 2016;32:237\u201342.","journal-title":"J Bone Miner Res"},{"key":"1045_CR40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. International agency for research on cancer handbook working group. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med. 2016;375:794\u20138.","journal-title":"N Engl J Med"},{"issue":"Jul","key":"1045_CR41","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(Jul):804\u201314.","journal-title":"Nat Med"},{"key":"1045_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","volume":"44","author":"J Frystyk","year":"1995","unstructured":"Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism. 1995;44:37\u201344.","journal-title":"Metabolism."},{"key":"1045_CR43","doi-asserted-by":"publisher","first-page":"291546","DOI":"10.1155\/2013\/291546","volume":"2013","author":"G De Pergola","year":"2013","unstructured":"De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.","journal-title":"J Obes"},{"issue":"Feb","key":"1045_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12(Feb):159\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"May","key":"1045_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2017.09.014","volume":"466","author":"C G\u00e9rard","year":"2018","unstructured":"G\u00e9rard C, Brown KA. Obesity and breast cancer - Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Mol Cell Endocrinol. 2018;466(May):15\u201330.","journal-title":"Mol Cell Endocrinol"},{"key":"1045_CR46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"63","author":"EH Allott","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63:800\u20139.","journal-title":"Eur Urol"},{"key":"1045_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fonc.2015.00230","volume":"5","author":"PG Vigneri","year":"2015","unstructured":"Vigneri PG, Tirr\u00f2 E, Pennisi MS, Massimino M, Stella S, Romano C, et al. The insulin\/IGF system in colorectal cancer development and resistance to therapy. Front Oncol. 2015;5:230.","journal-title":"Front Oncol"},{"issue":"Feb","key":"1045_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tem.2011.10.003","volume":"23","author":"SE Bulun","year":"2012","unstructured":"Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23(Feb):83\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"1045_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/cncr.28383","volume":"120","author":"R Chu","year":"2014","unstructured":"Chu R, van Hasselt A, Vlantis AC, Ng EK, Liu SY, Fan MD, et al. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer. Cancer. 2014;120:142\u201353.","journal-title":"Cancer."},{"key":"1045_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/13813450801954303","volume":"114","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71\u201383.","journal-title":"Arch Physiol Biochem"},{"key":"1045_CR51","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10549-011-1789-3","volume":"131","author":"X Sun","year":"2012","unstructured":"Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Jerry DJ, Schneider SS, et al. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat. 2012;131:1003\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"1045_CR52","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.urology.2008.06.001","volume":"72","author":"BR Lane","year":"2008","unstructured":"Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy. Urology. 2008;72:1240\u20135.","journal-title":"Urology."},{"key":"1045_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10:455\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"1045_CR54","doi-asserted-by":"publisher","first-page":"28668","DOI":"10.1074\/jbc.M301695200","volume":"278","author":"S Catalano","year":"2003","unstructured":"Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, et al. Leptin enhances, via AP-1, expression of aromatase in the CF-7 cell line*. J Biol Chem. 2003;278:28668\u201376.","journal-title":"J Biol Chem"},{"key":"1045_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1677\/ERC-09-0340","volume":"17","author":"R Fusco","year":"2010","unstructured":"Fusco R, Galgani M, Procaccini C, Franco R, Pirozzi G, Fucci L, et al. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Endocr Relat Cancer. 2010;17:373\u201382.","journal-title":"Endocr Relat Cancer"},{"key":"1045_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.orcp.2018.01.005","volume":"12","author":"A Tarasiuk","year":"2018","unstructured":"Tarasiuk A, Mosi\u0144ska P, Fichna J. The mechanisms linking obesity to colon cancer: An overview. Obes Res Clin Pract. 2018;12:251\u20139.","journal-title":"Obes Res Clin Pract"},{"key":"1045_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ijc.11668","volume":"109","author":"P Stattin","year":"2004","unstructured":"Stattin P, Lukanova A, Biessy C, S\u00f6derberg S, Palmqvist R, Kaaks R, et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer. 2004;109:149\u201352.","journal-title":"Int J Cancer"},{"key":"1045_CR58","doi-asserted-by":"publisher","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","volume":"86","author":"D Barb","year":"2007","unstructured":"Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007;86:s858\u201366.","journal-title":"Am J Clin Nutr"},{"key":"1045_CR59","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.bjc.6604166","volume":"98","author":"ME Grossmann","year":"2008","unstructured":"Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer. 2008;98:370\u20139.","journal-title":"Br J Cancer"},{"key":"1045_CR60","first-page":"479","volume":"20","author":"K Yoneda","year":"2008","unstructured":"Yoneda K, Tomimoto A, Endo H, Iida H, Sugiyama M, Takahashi H, et al. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep. 2008;20:479\u201383.","journal-title":"Oncol Rep"},{"key":"1045_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","volume":"4","author":"PG Morris","year":"2011","unstructured":"Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res. 2011;4:1021\u20139.","journal-title":"Cancer Prev Res"},{"key":"1045_CR62","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","volume":"18","author":"RCM van Kruijsdijk","year":"2009","unstructured":"van Kruijsdijk RCM, van der Wall E, Visseren FLJ. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009;18:2569\u201378.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1045_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","volume":"1229","author":"AE Harvey","year":"2011","unstructured":"Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 2011;1229:45\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"1045_CR64","doi-asserted-by":"publisher","first-page":"274585","DOI":"10.1155\/2015\/274585","volume":"2015","author":"S Balaban","year":"2015","unstructured":"Balaban S, Lee LS, Schreuder M, Hoy AJ. Obesity and cancer progression: is there a role of fatty acid metabolism? Biomed Res Int. 2015;2015:274585.","journal-title":"Biomed Res Int"},{"key":"1045_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0688-8","volume":"20","author":"DF Argolo","year":"2018","unstructured":"Argolo DF, Hudis CA, Iyengar NM. The impact of obesity on breast cancer. Curr Oncol Rep. 2018;20:47.","journal-title":"Curr Oncol Rep"},{"key":"1045_CR66","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/cncr.29440","volume":"121","author":"MS Shah","year":"2015","unstructured":"Shah MS, Fogelman DR, Raghav KP, Heymach JV, Tran HT, Jiang ZQ, et al. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer. Cancer. 2015;121:2968\u201375.","journal-title":"Cancer."},{"key":"1045_CR67","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10715762.2013.772604","volume":"47","author":"AB Crujeiras","year":"2013","unstructured":"Crujeiras AB, D\u00edaz-Lagares A, Carreira MC, Amil M, Casanueva FF. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res. 2013;47:243\u201356.","journal-title":"Free Radic Res"},{"key":"1045_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-015-3514-0","volume":"153","author":"PK Mahalingaiah","year":"2015","unstructured":"Mahalingaiah PK, Ponnusamy L, Singh KP. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells. Breast Cancer Res Treat. 2015;153:41\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"1045_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-016-0418-8","volume":"35","author":"UK Udensi","year":"2016","unstructured":"Udensi UK, Tchounwou PB. Oxidative stress in prostate hyperplasia and carcinogenesis. J Exp Clin Cancer Res. 2016;35:139.","journal-title":"J Exp Clin Cancer Res"},{"key":"1045_CR70","first-page":"4759","volume":"37","author":"F Carini","year":"2017","unstructured":"Carini F, Mazzola M, Rappa F, Jurjus A, Geagea AG, Al Kattar S, et al. Colorectal carcinogenesis: role of oxidative stress and antioxidants. Anticancer Res. 2017;37:4759\u201366.","journal-title":"Anticancer Res"},{"key":"1045_CR71","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/PPO.0000000000000049","volume":"20","author":"CJ Rogers","year":"2014","unstructured":"Rogers CJ, Prabhu KS, Vijay-Kumar M. The microbiome and obesity-an established risk for certain types of cancer. Cancer J. 2014;20:176\u201380.","journal-title":"Cancer J"},{"key":"1045_CR72","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","volume":"15","author":"PD Cani","year":"2018","unstructured":"Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15:671\u201382.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1045_CR73","doi-asserted-by":"publisher","first-page":"djv147","DOI":"10.1093\/jnci\/djv147","volume":"107","author":"JJ Goedert","year":"2015","unstructured":"Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst. 2015;107:djv147.","journal-title":"J Natl Cancer Inst"},{"key":"1045_CR74","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos DM, Ayangbesan A, O\u2019Malley P, Lewicki P, Barlow L, Barbieri CE, et al. The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study. Urology. 2018;111:122\u20138.","journal-title":"Urology."},{"key":"1045_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-018-8989-4","volume":"66","author":"I B\u00e4hr","year":"2018","unstructured":"B\u00e4hr I, Jahn J, Zipprich A, Pahlow I, Spielmann J, Kielstein H. Impaired natural killer cell subset phenotypes in human obesity. Immunol Res. 2018;66:234\u201344.","journal-title":"Immunol Res"},{"key":"1045_CR76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/epirev\/mxx005","volume":"39","author":"AM Mondul","year":"2017","unstructured":"Mondul AM, Weinstein SJ, Layne TM, Albanes D. Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev. 2017;39:28\u201348.","journal-title":"Epidemiol Rev"},{"key":"1045_CR77","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1200\/JCO.2011.35.7566","volume":"29","author":"Y Ma","year":"2011","unstructured":"Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011;29:3775\u201382.","journal-title":"J Clin Oncol"},{"key":"1045_CR78","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/1055-9965.EPI-10-1141","volume":"20","author":"M Touvier","year":"2011","unstructured":"Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003\u201316.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1045_CR79","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/nu12061798","volume":"12","author":"M Negri","year":"2020","unstructured":"Negri M, Gentile A, de Angelis C, Mont\u00f2 T, Patalano R, Colao A, et al. Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells. Nutrients. 2020;12:1798.","journal-title":"Nutrients"},{"key":"1045_CR80","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00432-014-1706-3","volume":"140","author":"Y Xu","year":"2014","unstructured":"Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z, et al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol. 2014;140:1465\u201377.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1045_CR81","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/1055-9965.EPI-14-0115","volume":"23","author":"AR Kristal","year":"2014","unstructured":"Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, et al. Plasma vitamin D and prostate cancer risk: results from the selenium and vitamin E cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014;23:1494\u2013504.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1045_CR82","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1158\/1055-9965.EPI-13-1340","volume":"23","author":"JM Schenk","year":"2014","unstructured":"Schenk JM, Till CA, Tangen CM, Goodman PJ, Song X, Torkko KC, et al. Serum 25- hydroxyvitamin D concentrations and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014;23:1484\u201393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1045_CR83","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/nu9040378","volume":"9","author":"FL Miles","year":"2017","unstructured":"Miles FL, Goodman PJ, Tangen C, Torkko KC, Schenk JM, Song X, et al. Interactions of the insulin-like growth factor axis and vitamin D in prostate cancer risk in the prostate cancer prevention trial. Nutrients. 2017;9:378.","journal-title":"Nutrients"},{"key":"1045_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62182-w","volume":"10","author":"V Nair-Shalliker","year":"2020","unstructured":"Nair-Shalliker V, Bang A, Egger S, Clements M, Gardiner RA, Kricker A, et al. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Sci Rep. 2020;10:7736.","journal-title":"Sci Rep"},{"key":"1045_CR85","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10552-015-0665-6","volume":"26","author":"GC Chen","year":"2015","unstructured":"Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer Causes Control. 2015;26:1719\u201328.27.","journal-title":"Cancer Causes Control"},{"key":"1045_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000374072","volume":"36","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wang S, Che X, Li X. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem. 2015;36:299\u2013305.","journal-title":"Cell Physiol Biochem"},{"key":"1045_CR87","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","volume":"4","author":"M Harvie","year":"2003","unstructured":"Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev. 2003;4:157\u201373.","journal-title":"Obes Rev"},{"key":"1045_CR88","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10549-012-2012-x","volume":"133","author":"E Amir","year":"2012","unstructured":"Amir E, Cecchini RS, Ganz PA. et al. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat. 2012;133:1077\u201388.","journal-title":"Breast Cancer Res Treat"},{"key":"1045_CR89","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.annonc.2020.01.066","volume":"31","author":"N Murphy","year":"2020","unstructured":"Murphy N, Knuppel A, Papadimitriou N, Martin RM, Tsilidis KK, Smith-Byrne K. et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ~430 000 women. Ann Oncol. 2020;31:641\u20139.","journal-title":"Ann Oncol"},{"key":"1045_CR90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.33549\/physiolres.930848","volume":"55","author":"D Housa","year":"2006","unstructured":"Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res. 2006;55:233\u201344.","journal-title":"Physiol Res"},{"key":"1045_CR91","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/1055-9965.EPI-06-0075","volume":"15","author":"Y Cui","year":"2006","unstructured":"Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomark Prev. 2006;15:1427\u201337.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1045_CR92","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3691","volume":"14","author":"D Feldman","year":"2014","unstructured":"Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342\u201357.","journal-title":"Nat Rev Cancer"},{"key":"1045_CR93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33\u201344.","journal-title":"N Engl J Med"},{"key":"1045_CR94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","volume":"51","author":"AV Krishnan","year":"2011","unstructured":"Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311\u201336.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1045_CR95","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3109\/13880209.2014.988274","volume":"53","author":"M Giammanco","year":"2015","unstructured":"Giammanco M, Di Majo D, La Guardia M, Aiello S, Crescimannno M, Flandina C, et al. Vitamin D in cancer chemoprevention. Pharm. Biol. 2015;53:1399\u2013434.","journal-title":"Pharm. Biol."},{"key":"1045_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BJ20110744","volume":"441","author":"JC Fleet","year":"2012","unstructured":"Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441:61\u201376.","journal-title":"Biochem J"},{"key":"1045_CR97","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/bjc.2014.294","volume":"111","author":"N Keum","year":"2014","unstructured":"Keum N, Giovannucci E. Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer. 2014;111:976\u201380.","journal-title":"Br J Cancer"},{"key":"1045_CR98","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7326\/0003-4819-155-12-201112200-00005","volume":"155","author":"M Chung","year":"2011","unstructured":"Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:827\u201338.","journal-title":"Ann Intern Med"},{"key":"1045_CR99","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMoa055222","volume":"354","author":"J Wactawski-Wende","year":"2006","unstructured":"Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O\u2019Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684\u201396.","journal-title":"N Engl J Med"},{"key":"1045_CR100","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","volume":"85","author":"JM Lappe","year":"2007","unstructured":"Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586\u201391.","journal-title":"Am J Clin Nutr"},{"key":"1045_CR101","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/bmj.326.7387.469","volume":"326","author":"DP Trivedi","year":"2003","unstructured":"Trivedi DP, Doll R, Khaw K-T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ. 2003;326:469.","journal-title":"BMJ."},{"key":"1045_CR102","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1001\/archinte.167.16.1730","volume":"167","author":"P Autier","year":"2007","unstructured":"Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007;167:1730\u20137.","journal-title":"Arch. Intern. Med."},{"key":"1045_CR103","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/annonc\/mdz059","volume":"30","author":"N Keum","year":"2019","unstructured":"Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann. Oncol. 2019;30:733\u201343.","journal-title":"Ann. Oncol."},{"key":"1045_CR104","first-page":"36","volume":"33","author":"J Manson","year":"2019","unstructured":"Manson J. Vitamin D and omega-3 supplements for preventing cancer and other chronic diseases. Oncology . 2019;33:36\u20138.","journal-title":"Oncology"},{"key":"1045_CR105","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/jama.2017.2115","volume":"317","author":"J Lappe","year":"2017","unstructured":"Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, et al. Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA. 2017;317:1234\u201343.","journal-title":"JAMA."},{"key":"1045_CR106","doi-asserted-by":"publisher","first-page":"E886","DOI":"10.1210\/jc.2012-3369","volume":"98","author":"SA Shapses","year":"2013","unstructured":"Shapses SA, Lee EJ, Sukumar D, Durazo-Arvizu R, Schneider SH. The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women. J Clin Endocrinol Metab. 2013;98:E886\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR107","doi-asserted-by":"publisher","first-page":"e0192596","DOI":"10.1371\/journal.pone.0192596","volume":"13","author":"E Saarnio","year":"2018","unstructured":"Saarnio E, Pekkinen M, Itkonen ST, Kemi V, Karp H, Ivaska KK, et al. Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone? PLoS ONE. 2018;13:e0192596.","journal-title":"PLoS ONE"},{"key":"1045_CR108","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","volume":"15","author":"AG Renehan","year":"2015","unstructured":"Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1045_CR109","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2213-8587(17)30357-1","volume":"5","author":"P Autier","year":"2017","unstructured":"Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5:986\u20131004.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1045_CR110","doi-asserted-by":"publisher","first-page":"e0180512","DOI":"10.1371\/journal.pone.0180512","volume":"12","author":"L Rejnmark","year":"2017","unstructured":"Rejnmark L, Bislev LS, Cashman KD, Eir\u00edksdottir G, Gaksch M, Gr\u00fcbler M, et al. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS ONE. 2017;12:e0180512.","journal-title":"PLoS ONE"},{"key":"1045_CR111","doi-asserted-by":"crossref","unstructured":"Manousaki D, Richards JB. Low vitamin D levels as a risk factor for cancer. BMJ. 2017;359:j4952.","DOI":"10.1136\/bmj.j4952"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01045-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T23:04:28Z","timestamp":1676070268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01045-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1038\/s41366-021-01045-4","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}